nMRCGP exam update - Evidence for aspirin use
Contributed by Dr Louise Newson, a GP in the West Midlands. Read more
Metabolic and cardiovascular risk factors must be monitored in these patients, say a collection of advocacy groups including the National Obesity Forum.
Weight gain is a multi-pronged problem in schizophrenia. As well as issues over cardiovascular health, there are concerns that some patients discontinue antipsychotic drugs when they put on weight.
Although the management of severe psychiatric care should continue to be the preserve of specialist services, GPs should be getting more involved with day-to-day management of these patients, say the charities.
The GMS quality framework mental health domain has 23 points for giving patients with schizophrenia health promotion advice depending on their health status. But in the manifesto developed by the advocacy groups, GPs are urged to embrace this role 'enthusiastically'. It called on GPs to set up screening systems to help manage metabolic and cardiovascular risks.
This could lead to referring a patient back to secondary care for a review of their antipsychotic medication.
Dr Dave Tomson, a Tyneside GP with an interest in mental health, called for more flexible support from mental health services.
Contributed by Dr Louise Newson, a GP in the West Midlands. Read more
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more
Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more
Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more
Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more
The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more
Comments
Only registered users may comment. Log in now or register for a free account.